Gary Clark: Unfiltered

The children's book giant is selling its landmark properties. It's not a retreat, but a strategic pivot to fuel growth and reward shareholders.

A deep dive into Liberty Defense's latest financing, analyzing how it plans to use fresh capital to scale its innovative HEXWAVE threat detection system.

A shrewd, low-cost acquisition positions Rio Silver to consolidate a key mineral district as global silver prices soar and supply tightens.

Promising survival data and a novel biomarker strategy from BriaCell could reshape the metastatic breast cancer treatment and investment landscape.

The #2 U.S. outpatient imaging firm is going public to pay down debt. Is it a picture of health for investors or a risky PE-driven exit play?

The media giant secured a crucial debt deal, extending maturities and shedding covenants. But is it a strategic masterstroke or a distressed maneuver?

Endeavour Silver swaps high-cost debt for cheap capital in a $300M+ deal, aiming to unleash one of the world's largest undeveloped silver projects.

Wabtec's major acquisition isn't just another deal; it's a strategic move to dominate the future of smart railways. Here's why it matters.

Companion Spine’s acquisition of Paradigm Spine is more than a deal; it’s a masterstroke by the Viscogliosi Brothers to dominate the future of spine surgery.

Beyond a simple refi, Ducommun’s new credit line is a strategic power play, positioning the A&D supplier to hunt for acquisitions and execute its VISION 2027.

With a C$150M financing deal in tatters and cash running out, Ascot Resources faces potential creditor protection, casting a shadow over its BC gold mine.

PENN Entertainment's new M Resort tower is more than a hotel; it's a key move in a national retail strategy funded by savvy REIT financing.

As Medincell preps its H1 results, analysis reveals how its BEPO® tech and key partnerships are turning blockbuster potential into tangible revenue.

Saga Communications pitches its digital turnaround to investors as legacy radio revenues decline. Can a "blended advertising" strategy tune into new growth?

Beyond the headlines of its 40-state footprint, Standard Premium's expansion is a calculated move powered by a $115M war chest and regulatory savvy.

AI and 3D bioprinting reveal ultrasound can supercharge a brain cancer drug, charting a new course for NeOnc Technologies and CNS oncology.

A permanent tax break allows businesses to write off 100% of a yacht's cost. But navigating the IRS's strict rules is the real challenge.

Klarna’s record Black Friday growth far outpaced retail, revealing how savvy consumers use BNPL as a strategic tool in a cautious economic climate.

YY Group's new bank contract isn't just about maintenance; it's a strategic entry into finance, powered by AI and IoT, shaking up Singapore's IFM market.

BioCardia is showcasing its advanced cell therapy in Frankfurt, a strategic move to capture a slice of the $55B heart failure market. What's the play?